Towa Pharmaceutical Co., Ltd.
Notice of Parent Company’s Financial Results | June 24, 2026
Reporting the financial results of the parent company, Yoshida Office Co., Ltd., for the fiscal year ending March 2026. While sales figures are unspecified, net assets are 15,685,795 thousand yen, and net income for the period is 1,762,273 thousand yen. Disclosures include capital surplus and retained earnings.
Key Figures
- Sales: 1,846,262 thousand yen
- Net income for the period: 1,762,273 thousand yen
- Net assets: 15,685,795 thousand yen
AI要約
Overview of Parent Company, etc.
Reporting the financial results of Yoshida Office Co., Ltd., for the fiscal year ending March 2026. Total assets amount to 15,699,523 thousand yen, with net assets of 15,685,795 thousand yen. Sales are 1,846,262 thousand yen, and net income for the period is 1,762,273 thousand yen. Details of capital surplus and retained earnings are also disclosed, providing an overview of the capital structure and financial condition.
Financial Status and Shareholder Composition of Parent Company
The parent company's shareholders include multiple investors, with Itturo Yoshida holding a voting rights ratio of 40.85%. Major shareholders include the NPO Méséna and Sports Promotion Association, as well as individual shareholders Tomo Kuni and Eimi Yamamoto, owning 80,500 shares and 16,754 shares respectively. The parent company's financial condition is solid, with treasury stock holdings totaling 1,900 thousand yen.
Tohwa Pharmaceutical Co., Ltd.
Company overview · Stock price · Financial data · All IR
